We are live on ! Find out more
LC

Lunate Capital Portfolio holdings

AUM $196M
1-Year Est. Return 84.21%
This Fund
S&P 500
This Quarter Est. Return
-2.23%
1 Year Est. Return
+84.21%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$120M
AUM Growth
-$144M
Cap. Flow
-$166M
Cap. Flow %
-138.18%
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
–
Reduced
1
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
RVMD icon
Revolution Medicines
RVMD
+$166M

Sector Composition

Rank Sector Weight
1 Healthcare 47.8%
2 Technology 35.2%
3 Real Estate 16.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RVMD icon
1
Revolution Medicines
RVMD
$40.1B
$53.4M 44.36%
549,050
-1,647,150
-75% -$166M
SAIL
2
SailPoint Inc
SAIL
$8.12B
$39.7M 33%
3,000,000
– –
LINE
3
Lineage Inc
LINE
$9.32B
$19.7M 16.33%
600,000
– –
NMRA icon
4
Neumora Therapeutics
NMRA
$289M
$4.14M 3.44%
2,124,143
– –
NAVN
5
Navan Inc
NAVN
$5.65B
$2.65M 2.2%
200,000
– –
RVMDW icon
6
Revolution Medicines Inc Warrant
RVMDW
$105M
$806K 0.67%
450,000
– –

Similar funds

NWA
Navis Wealth Advisors Rye Brook, New York $196M AUM 33.05% 1-Year Est. Return
FCM
FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return
LWA
Legacy Wealth Advisors Miami, Florida $196M AUM
CA
Continental Advisors Park City, Utah $196M AUM 24.19% 1-Year Est. Return
SF
SWP Financial San Diego, California $196M AUM 14.56% 1-Year Est. Return
CCP
Cyrus Capital Partners New York $196M AUM 123.68% 1-Year Est. Return
PAM
Peninsula Asset Management Bradenton, Florida $196M AUM 10.62% 1-Year Est. Return
MAMF
Mirabaud Asset Management (France) Paris, France $196M AUM

Lunate Capital's Q1 2026 Portfolio in Review

As of Q1 2026, Lunate Capital held 6 positions worth $120M, down 54% from $264M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Lunate Capital withdrew a net $166M in Q1 2026, reducing 1 holding. Its largest reduction was Revolution Medicines, cutting an estimated $166M.

By sector, the portfolio is most concentrated in Healthcare at 48% of assets, down from 68% a quarter earlier, followed by Technology and Real Estate.

  • Lunate Capital's biggest Q1 2026 reduction was Revolution Medicines, cutting an estimated $166M.
  • Lunate Capital's ten largest holdings make up 100% of its $120M portfolio in Q1 2026.
  • Lunate Capital opened 0 new positions and closed 0 in Q1 2026.
  • Lunate Capital's portfolio value fell 54% quarter-over-quarter to $120M.

Based on Lunate Capital's 13F filing for Q1 2026, filed 16 Apr 2026.